NewLink Genetics Corp. | Ownership
Companies that own NewLink Genetics Corp.
BlackRock Fund Advisors
2,119,828
5.7%
-4,762
0%
06/30/2018
Redmile Group LLC
1,611,746
4.33%
-442,454
0.16%
06/30/2018
The Vanguard Group, Inc.
1,449,573
3.9%
162,284
0%
06/30/2018
T. Rowe Price Associates, Inc.
759,607
2.04%
-649,597
0%
06/30/2018
First Eagle Investment Management LLC
759,250
2.04%
-1,587,050
0%
06/30/2018
Connor, Clark & Lunn Investment Management Ltd.
673,885
1.81%
114,650
0.01%
06/30/2018
Baker Bros. Advisors LP
507,273
1.36%
0
0.01%
06/30/2018
Wells Fargo Clearing Services LLC
506,960
1.36%
110,014
0%
06/30/2018
SSgA Funds Management, Inc.
473,743
1.27%
-21,754
0%
06/30/2018
JPMorgan Investment Management, Inc.
451,610
1.21%
-28,512
0%
06/30/2018
| Address |
2503 South Loop Drive
Ames Iowa 50010
United States
|
|
Employees
|
- |
| Website |
http://www.newlinkgenetics.com |
| Updated |
07/08/2019 |
| NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. |
